Zebrafish Microphthalmia/Anophthalmia Models

Introduction

Microphthalmia and anophthalmia (MA) are congenital disorders of abnormal eye development. Microphthalmia is characterized by an abnormally small eye caused by incomplete ocular development, whereas anophthalmia refers to complete or near-complete absence of ocular tissue. The conditions may occur unilaterally or bilaterally and can present as isolated eye abnormalities or as part of multisystem genetic syndromes. Patients may experience severe visual impairment or blindness, often accompanied by additional ocular abnormalities such as coloboma, microcornea, cataracts, or retinal defects.

MA has a genetically heterogeneous etiology involving genes that regulate eye-field specification, optic vesicle formation, retinal differentiation, and ocular tissue growth. Human variants in SOX2, OTX2, RAX, PAX6, MAB21L2, GDF6, and BMP4, among others, have been associated with the microphthalmia-anophthalmia-coloboma spectrum. However, the functional consequences of many rare variants remain difficult to establish, and the developmental mechanisms linking gene disruption to specific ocular phenotypes are incompletely understood. Zebrafish genetic models provide an experimentally tractable system for investigating these mechanisms and evaluating genetic or pharmacological interventions during early eye development.

Why Zebrafish?

• Rapid eye development enables analysis of early developmental defects.
• Transparent embryos allow direct visualization of ocular morphogenesis.
• Conserved eye-development genes support human variant studies.
• Genetic models enable rapid genotype–phenotype analysis.

Available Zebrafish Disease Models

Unlike acquired retinal diseases, MA models are primarily generated through genetic disruption of conserved eye-development genes. The following models have well-documented ocular phenotypes relevant to human microphthalmia/anophthalmia research.

Model selection note: These models represent different developmental mechanisms rather than interchangeable MA models. rx3 is particularly suitable for early eye-field and anophthalmia studies, while mab21l2, rbm24a, and otx2b are more appropriate for microphthalmia and genetically defined ocular developmental disorders.

Phenotypic Evaluation

Key Applications

• Genetic Variant Functional Validation: Determine whether candidate variants in SOX2, MAB21L2, OTX2, RAX, and related genes disrupt normal eye development.
• Eye-Field Specification Studies: Investigate early molecular events controlling eye-field formation, optic vesicle evagination, and optic cup morphogenesis.
• Microphthalmia and Anophthalmia Mechanism Studies: Define how impaired progenitor survival, proliferation, differentiation, or tissue morphogenesis contributes to abnormal eye size or failure of eye formation.
• Gene Function and Rescue Studies: Evaluate genetic complementation or pathway modulation to determine whether developmental ocular phenotypes can be rescued.
• Developmental Therapeutic Screening: Screen candidate compounds or pathway modulators for their ability to improve specific developmental phenotypes associated with genetically defined ocular disorders.

Study Examples

The study characterized zebrafish mab21l2 loss-of-function mutants as a model of MAB21L2-associated ocular developmental disorders. Mutant embryos developed small and malformed eyes, coloboma, abnormal lenses, and corneal dysgenesis. Reduced proliferation and increased cell death were observed in developing lens and optic stalk tissues, while the choroid fissure failed to undergo normal morphogenesis.

Fig. 1. mab21l2 deficiency causes microphthalmia accompanied by lens, corneal, and optic cup abnormalities (Johnson AD, et al., 2019).

Reference

1. Johnson AD, et al. Zebrafish mab21l2 mutants possess severe defects in optic cup morphogenesis, lens and cornea development. Developmental Dynamics. 2019.